American Association for Cancer Research

AACR Cancer Policy Monitor

Bookmark and Share
June 2011



Resolution recognizing National Cancer Research Month unanimously approved               

In a fitting way to close out National Cancer Research Month, the U.S. Senate unanimously approved a resolution on May 27 recognizing the importance of cancer research.

Senate Resolution 172, introduced by Sen. Dianne Feinstein (D-Calif.) and Sen. Kay Bailey Hutchison (R-Texas), officially designated May 2011 as National Cancer Research Month and paid tribute to the scientists and clinicians across the United States dedicated to fighting cancer.

Seventeen additional senators served as cosponsors of the resolution and it was endorsed by more than 65 national organizations and cancer centers.

In the House, Rep. Brian Higgins (D-NY), who represents Roswell Park Cancer Institute, submitted a statement into the Congressional Record encouraging strong, sustained investment in the National Institutes of Health and the National Cancer Institute. “The only failure in research is when you quit or are forced to quit due to lack of funding. National Cancer Research Month provides us a reminder of those risks, and also the immense reward that arrives when promising research alleviates the suffering of cancer patients,” said Higgins in the statement.

Throughout the month, the AACR worked with lawmakers and the cancer community at large to raise awareness about advances in cancer research.

In collaboration with the Association of American Cancer Institutes (AACI), the American Society of Clinical Oncology (ASCO), and Friends of Cancer Research, the AACR hosted a Hill Day on May 11. More than 80 participants from 32 states met on Capitol Hill and attended more than 150 meetings with members of Congress and congressional aides to emphasize the importance of increased federal funding for cancer research.

Additionally, the AACR sponsored national, outdoor, radio and web advertising, with special focus in the Washington, D.C., area.


Read more from the June edition of the AACR Cancer Policy Monitor: